Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

NANO-X IMAGING LTD.

(NNOX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Nanox Imaging Shares Rise 15% on 510(k) Application for Imaging System

06/17/2021 | 10:43am EDT

By Chris Wack

Nanox Imaging Ltd. shares were up 15% to $32.25 after the company said it has submitted a 510(k) premarket notification application to the U.S. Food and Drug Administration for the first version of its multisource Nanox.ARC 3-D digital tomosynthesis system.

The company said the first version of the multisource Nanox.ARC will be followed by future Nanox.ARC versions.

Nanox.ARC is a 3-D tomosynthesis imaging system that produces scans of a human body part. The system is being designed for easy setup and operation with multiple alternately switched X-ray tubes arranged around the patient.

Nanox received FDA clearance of its single source Nanox Cart X-Ray System in April.

Write to Chris Wack at chris.wack@wsj.com

(END) Dow Jones Newswires

06-17-21 1042ET

All news about NANO-X IMAGING LTD.
07/27Nanox to Announce Second Quarter 2021 Financial and Operating Results on Tues..
GL
07/12NANO X IMAGING : Signs Nigeria Distribution Deal With EiLEENO Pharma; Shares Up ..
MT
07/12Nano-X Imaging Ltd. Signs MSaaS Agreement with EiLEENO Pharma for the Deploym..
CI
07/12NANOX : Signs MSaaS Agreement for the Deployment of 1,000 Nanox : Systems in Nig..
BU
07/01Nanox to Present at the Ladenburg Thalmann Healthcare Conference
GL
06/17Nanox Imaging Shares Rise 15% on 510(k) Application for Imaging System
DJ
06/17SECTOR UPDATE : Health Care Stocks Decline in Premarket Thursday
MT
06/17NANO X IMAGING : Submits FDA 510(k) Application for 3D Digital Tomosynthesis Sys..
MT
06/17NANO X IMAGING : 510(K) Class II FDA submission seeks clearance of the first ver..
PU
06/17Nanox Announces FDA 510(k) Submission for First Version of Multi-Source Nanox..
GL
More news
Financials (USD)
Sales 2021 - - -
Net income 2021 -56,2 M - -
Net cash 2021 167 M - -
P/E ratio 2021 -24,0x
Yield 2021 -
Capitalization 1 349 M 1 349 M -
EV / Sales 2021 -
EV / Sales 2022 112x
Nbr of Employees 50
Free-Float 72,4%
Chart NANO-X IMAGING LTD.
Duration : Period :
Nano-X Imaging Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NANO-X IMAGING LTD.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 28,35 $
Average target price 45,50 $
Spread / Average Target 60,5%
EPS Revisions
Managers and Directors
Ran Poliakine Chairman & Chief Executive Officer
Itzhak Maayan Chief Financial Officer
Amir Ben-Shalom Chief Scientific Officer
Ofir Koren Chief Technology Officer
Elad Toister Vice President-Engineering
Sector and Competitors
1st jan.Capi. (M$)
NANO-X IMAGING LTD.-37.91%1 349
BEIJING WANDONG MEDICAL TECHNOLOGY CO., LTD.130.24%1 932
SONOSCAPE MEDICAL CORP.3.36%1 663
RAY CO., LTD.17.07%360
VIEWORKS CO., LTD.21.09%301
SDI GROUP PLC67.36%276